FEATURES OF THE PATHOMORPHOLOGICAL DIAGNOSIS OF MICROCRYSTALLINE ARTHROPATHIES IN THE PRACTICE OF SURGICAL MATERIAL EXAMINATION

The development of microcrystalline arthritides is most frequently associated with the formation of monosodium urate (MSU) and calcium pyrophosphate (CPP) crystals. Their identification is of crucial importance in recognizing these diseases.
Objective: to determine the possibilities of histological techniques in identifying MSU and CPP crystals and to evaluate the effectiveness of the techniques.
Subjects and methods. Twenty-four tissue blocks (fragments of the affected areas of the elbow joint, the interphalangeal joint of the index finger, and hip joint) from 7 patients were examined. Paraffin sections were stained with a 0.5% alcohol solution of eosin, as well as with hematoxylin and eosin. Tissue specimens were examined and digitized using an AxioScope.A1 stereo microscope with Zenblue software (Carl Zeiss MicroImaging GmbH, Germany).
Results and discussion. When staining the tissue sections with hematoxylin and eosin, microcrystals were not visualized; the major portions of MSU crystals was dissolved during fixation and staining, whereas CPP crystals were masked with hematoxylin as focal basophilic aggregates. The staining technique with an alcohol solution of eosin and short formalin fixation (within 12 hours) made it possible to avoid dissolution of MSU crystals and to visualize both MSU and CPP crystals, and to determine their shape and color.
Conclusion. Light microscopy of the tissue sections stained with an alcohol solution of eosin along with short formalin fixation is a reliable method to differentiate MSU and CPP crystals. In patients undergoing endoprosthetic replacement, the significance of this technique for the pathomorphological study of surgical material consists in assessing inflammatory activity and in eliminating a disease, such as microcrystalline arthropathy.

1. Zhang W, Doherty M, Bardin T, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011;70:563. doi: 10.1136/ard.2010.139360

2. Gibson T. Hyperuricemia, gout and the kidney. Curr Opin Rheumatol. 2012 Mar;24(2):127-31. doi: 10.1097/BOR.0b013e32834f049f

3. Gonzalez EB. An update on the pathology and clinical management of gouty arthritis. Clin Rheumatol. 2012 Jan;31(1):13-21. doi: 10.1007/s10067-011-1877-0

4. Елисеев МС, Желябина ОВ. Сочетание подагры и болезни депонирования пирофосфатов кальция: трудности диагностики и лечения. РМЖ. Медицинское обозрение. 2017;(1):44-7. [Eliseev MS, Zhelyabina OV. The combination of gout and the disease of calcium pyrophosphate deposition: the difficulties of diagnosis and treatment. RMZh. Meditsinskoe Obozrenie. 2017;(1):44-7 (In Russ.)].]

5. Денисов ИС, Елисеев МС, Барскова ВГ. Исходы подагры. Обзор литературы. Часть I. Эпидемиология подагры, факторы риска и течение заболевания с развитием хронической тофусной формы. Научно-практическая ревматология. 2013;51(5):569-73. doi: 10.14412/1995-4484-2013-1550 [Denisov IS, Eliseev MS, Barskova VG. Gout outcomes. A review of literature. Part 1. Gout: Epidemiology, risk factors, course of the disease with the development of chronic tophus form. NauchnoPrakticheskaya Revmatologiya = Rheumatology Science and Practice. 2013;51(5):569-73. doi: 10.14412/1995-4484-2013-1550 (In Russ.)].

6. Sidari A, Hill E. Diagnosis and treatment of gout and pseudogout for everyday practice. Prim Care. 2018 Jun;45(2):213-36. doi: 10.1016/j.pop.2018.02.004

7. Елисеев МС, Желябина ОВ, Чикина МН. Возрастные особенности болезни депонирования кристаллов пирофосфата кальция. Научно-практическая ревматология. 2019;57(6):651-6. doi: 10.14412/1995-4484-2019-651-656 [Eliseev MS, Zhelyabina OV, Chikina MN. Age-related features of calcium pyrophosphate deposition disease. NauchnoPrakticheskaya Revmatologiya = Rheumatology Science and Practice. 2019;57(6):651-6. doi: 10.14412/1995-4484-2019-651-656 (In Russ.)].

8. Барскова ВГ, Елисеев МС, Владимиров ВА. Диагностика микрокристаллической патологии суставов методом поляризационной микроскопии (трактовка и методические рекомендации к исследованию. Современная ревматология. 2010;4(1):84-8. doi: 10.14412/1996-7012-2010-594 [Barskova VG, Eliseev MS, Vladimirov SA. Diagnosis of microcrystalline joint diseases by polarization microscopy: interpretation and guidelinesfor their study. Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2010;4(1):84-8. doi: 10.14412/1996-7012-2010-594 (In Russ.)].

9. Макаренко ЕВ. Подагра: современные принципы диагностики и лечения. Вестник ВГМУ. 2017;16(6):7-22. doi: 10.22263/2312-4156.2017.6.7 [Makarenko EV. Gout: modern principles of diagnosing and treatment. Vestnik VGMU. 2017;16(6):7-22. doi: 10.22263/2312-4156.2017.6.7 (In Russ.)].

10. Newberry SJ, FitzGerald JD, Motala A, et al. Diagnosis of gout: A systematic review in support of an American College of Physicians clinical practice guideline. Ann Intern Med. 2017;166(1):27-36. doi: 10.7326/M16-0462

11. Liu-Bryan R, Terkeltaub R. Chapter 5: Tophus Biology and Pathogenesis of Monosodium Urate Crystal-Induced Inflammation. In: Gout & Other Crystal Arthropathies. Elsevier; 2012. P. 59-71. doi: 10.1016/B978-1-4377-2864-4.10005-3

12. Ankli B, Kyburz D, Hirschmann A, et al. Calcium pyrophosphate deposition disease: a frequent finding in patients with long-standing erosive gout. Scand J Rheumatol. 2018;47(2):127-30. doi: 10.1080/03009742.2017.1332239

13. Барскова ВГ, Мукагова МВ, Северинова МА и др. Диагностика подагры. Сибирский медицинский журнал. 2012;(5):132-5. [Barskova VG, Mukagova MV, Severinova MA, et al. Gout diagnostics. Sibirskiy meditsinskiy zhurnal. 2012;112(5):132-5 (In Russ.)].

14. Sissons HA, Steiner GC, Bonar F, et al. Tumoral calcium pyrophosphate deposition disease. Skeletal Radiol. 1989;18(2):79- 87. doi: 10.1007/bf00350651

15. Кабалык МА, Дубиков АИ, Петрикеева ТЮ. Методы обнаружения кристаллов в суставном хряще: Часть 2. Научно-практическая ревматология. 2012;50(4):88-90. doi: 10.14412/1995-4484-2012-1118 [Kabalyk MA, Dubikov AI, Petrikeyeva TYu. Methods for detection of joint crystals: Status praesens. Part II. NauchnoPrakticheskaya Revmatologiya = Rheumatology Science and Practice. 2012;50(4):88-90. doi: 10.14412/1995-4484-2012-1118 (In Russ.)].

16. Dalbeth N, So A. Hyperuricaemia and gout: state of the art and future perspectives. Ann Rheum Dis. 2010;69(10):1738-43. doi: 10.1136/ard.2010.136218

17. Барскова ВГ. Рекомендации Европейской антиревматической лиги по терминологии и диагностике болезни депонирования кристаллов пирофосфата кальция: комментарии эксперта. Современная ревматология. 2011;5(2):6-8. doi: 10.14412/1996-7012-2011-661 [Barskova VG. European League Against Rheumatism recommendations for terminologyand diagnosis of calcium pyrophosphate crystal deposition disease: Expert comment. Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2011;5(2):6-8. doi: 10.14412/1996-7012-2011-661 (In Russ.)].

18. Барскова ВГ. Диагностика болезни депонирования кристаллов пирофосфата кальция (пирофосфатной артропатии). Русский медицинский журнал. 2012;20(7):350. [Barskova VG. Diagnosis of the disease of deposition of crystals of calcium pyrophosphate (pyrophosphate arthropathy). Russkiy Meditsinskiy Zhurnal. 2012;20(7):350 (In Russ.)].

19. Shidham V, Chivukula M, Basir Z, Shidman G. Evaluation of crystals in formalin fixed, paraffin embedded tissue sections for the differential diagnosis of pseudogout, gout, and tumoral calcinosis. Mod Pathol. 2001;14:806-10. doi: 10.1038/modpathol.3880394

20. Шостак НА. Пирофосфатная артропатия – подходы к диагностике. Русский медицинский журнал. 2015;25:1518-9. [Shostak NA. Pyrophosphate arthropathy – approaches to diagnosis. Russkiy Meditsinskiy Zhurnal. 2015;25:1518-9 (In Russ.)].